QuadraMune for preventing and beating COVID-19 By Dr. James

New Post Public Reply Private Reply Replies (0) Message Board
curncman
535
QuadraMune for preventing and beating COVID-19 By Dr. James D. Veltmeyer

By Dr. James D. Veltmeyer
Special to Village News

Last updated 9/4/2020 at 3:32am

A cavalcade of disinformation and outright lies have surrounded the spread of COVID-19 over the last five months. Americans have been subjected to numerous contradictory assertions and directives from global bureaucracies like the World Health Organization as well as the CDC, the surgeon general and Dr. Anthony Fauci.

It’s time to set the record straight and discuss the best ways of not just curing the coronavirus, but actually preventing it in the first place. And, as with most illnesses, it generally comes down to the immune system. Contrary to popular opinion, COVID-19 itself is not really killing anyone. What is killing a very minuscule number of coronavirus victims is the body’s immune system overreacting to the presence of the virus and causing widespread inflammation of body tissues and organs, such as the lungs. Inflammation caused by the hyper-reaction of the immune system is the cause of many illnesses physicians deal with on a daily basis. Chronic diseases like lupus and arthritis are auto-immune disorders. Common allergies are caused by the immune system identifying and overreacting to common and usually harmless outside substances, like pollen or dust, and causing that system to go into overdrive to fight the outside agent, even if that agent poses no health threat to the individual.

The reason most people diagnosed with COVID-19 are having no symptoms or only mild illnesses is that their immune systems are functioning normally; however, in older adults and individuals who have compromised immune systems, the immune system moves into “freakout” mode, causing massive inflammation often leading to either violent illness or death.

With COVID-19, the virus enters through lung type 2 epithelial cells. An excessive immune response results in the infiltration of inflammatory cells, called neutrophils, into the lungs. Neutrophils produce enzymes which destroy the fine structures of the lung needed for respiration to occur, also causing the leakage of water into the lungs. Protection from a virus is mediated by stimulation of the first layer of defense “innate” immunity: interferon-alpha production NK cell activity.

Additional production from the virus is enhanced by Th1 cells, which are part of the adaptive immune system and cause immunological memory and suppression of excessive inflammation inhibits NLRP3 and chemicals that are toxic to the lungs.

QuadraMune is a natural health product that offers an integrated and sustained attack on inflammation. It contains four main ingredients: Pterostilbene, Epigallocatechin gallate or EGCg, Sulforaphane and Thymoquinone. The first ingredient is used for immune stimulation and blocking inflammation. The second is a potent antioxidant, responsible for some of the health benefits of green tea. Sulforaphane is also an antioxidant and potent stimulator of endogenous detoxifying enzymes, responsible for the health benefits of broccoli. Finally, thymoquinone is a phytochemical compound found in the plant Nigella sativa.

In a clinical trial, pterostilbene was demonstrated to increase the ability of NK cells to kill target cancer cells. NK cells are cells of the body that directly kill viruses. In the same trial, pterostilbene increased the production of Interferon-gamma from T cells. Interferon-gamma is essential for antiviral Th1 immune memory. It also decreased CRP, the C-reactive protein, which is associated with death from COVID-19 and TNF which is produced by macrophages in the lungs and causes lung failure.

Sulforaphane protects the lungs from damage by activating the Nrf2 gene and suppresses the death of lung cells. It stimulates production of growth factors, stimulates fluid call surfactant to clear debris and prevents scar tissue formation.

EGCg protects from cell death induced by inflammatory mediators, inhibits alveolar macrophage hyperactivation, suppresses neutrophil activity in the lungs, reduces fibrosis and stimulates healing factors. It also stimulates T regulatory cells when needed to protect the body against autoimmunity and pathological inflammation.

Lastly, thymoquinone has an active ingredient chemically related to hydroxychloroquine which – despite the best efforts of the left-wing press to ridicule its efficacy – has been proven in study after study to work both as a preventative and greatly assist recovery in the early stages of COVID, is demonstrated to stimulate NK cells, which are antiviral, and is a potential antiviral itself based on its mechanistic effects on cells.

Like other viruses, COVID-19 can be avoided or – if contracted – its worst effects mitigated by a strong and effective immune system, just like the common cold, the various strains of influenza or other maladies that have plagued humanity for centuries.

Dr. James Veltmeyer is a prominent La Jolla physician voted “Top Doctor” in San Diego County in 2012, 2014, 2016, 2017 and 2019. Veltmeyer can be reached at dr.jamesveltmeyer@yahoo.com and by visiting http://drveltmeyer.com.

Therapeutic Solutions International Inc (TSOI) Stock Research Links

TSOI Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Advanta's Game-Changer: Acquiring Misr Hytech to Expand in Africa

Updated Category News Views 96

Advanta's Strategic Move into Africa Alright, let's cut to the chase. Advanta is making a big splash with its acquisition of Misr Hytech, a move that's going to shake things up in Africa's agricultural sector. This isn't just another merger to gloss over with your morning coffee. We're talking about a deal that's supposed to wrap up by January 31, 2027, bringing together...

Continue Reading
Dyania, NVIDIA Team Up: AI Transforming Patient Care

Updated Category News Views 61

Revving up efficiency in healthcare usually sounds like pie-in-the-sky talk, but every now and again, an innovation comes along that really stirs the pot. Enter Dyania Health's Synapsis AI, a clinical reasoning AI, teaming with NVIDIA's robust computing infrastructure. They're setting out to make sense of massive amounts of patient data, securely tucked behind a...

Continue Reading
Wiz Khalifa Ignites MJBizCon 2026 with Keynote and Music

Updated Category News Views 184

An Icon in Cannabis Culture Hits the Stage When you mix business with pleasure, you get something like what MJBizCon's cooking up this year. Wiz Khalifa, the man with a knack for turning passion into profit, is jumping onto the stage—not just as a performer, but also as a keynote speaker. On December 2, attendees are in for a treat as he steps into a new spotlight at...

Continue Reading
New Senior Care Location Opens in Broward County

Updated Category News Views 197

A Personal Mission Driving Business in Hollywood Dive deep into any community, and you'll often find stories that tug at the heartstrings—especially when they're about family. That's the case with Saudia Sital, a Broward County local who's just opened Always Best Care Senior Services in Hollywood, Florida. Her journey from personal caregiver to business owner isn't just...

Continue Reading
GTEC Faces Nasdaq Bid Price Compliance Challenge

Updated Category News Views 154

Greenland Technologies in a Tight Spot Man, stocks can be as unpredictable as a cat on a hot tin roof, and Greenland Technologies Holding Corporation (Nasdaq: GTEC) just got a cold splash of reality from Nasdaq. On November 10, 2026, they were handed a Notification Letter that ain’t exactly a love note. Their shares slipped below the one-buck hurdle, and Nasdaq isn’t...

Continue Reading
D-Wave's 9.5% Drop: Fraud Lawsuit Raises Investor Ire

Updated Category News Views 129

Shockwaves from D-Wave's Earnings Call August wasn't exactly a banner month for D-Wave Quantum, Inc. as their stock went down like a lead balloon following a lackluster earnings report. If you've ever had any skin in the game, you'd know a 9.5% drop isn't just peanuts—it's the equivalent of watching your prized racehorse stumble at the first hurdle. The financials spoke...

Continue Reading
First Horizon's $25M Bet: New Center Transforms Houston

Updated Category News Views 187

New Markets Tax Credits: A Game Changer First things first, if you're thinking this is some typical charitable write-off, think again. First Horizon Bank (NYSE: FHN) is deep in the mix of something pretty transformative in the world of finance and community support. They're not just throwing money at a problem and hoping it sticks. Nope, we're talking real strategy with a...

Continue Reading
Backdoor Reference Checks: A Hiring Minefield?

Updated Category News Views 157

What's Really Happening with Job References? Every job seeker has been there, right? You're all set, resume polished to a shine, references lined up like a choir ready to sing your praises, and then bam—you hear that employers are contacting folks you never listed. A new report from Zety highlights this eyebrow-raising trend, and it's got us all questioning the value...

Continue Reading
ADI Global Faces Investor Investigation Over Major Write-Down

Updated Category News Views 91

Towering Goodwill Falls and Investor Scrutiny Well, let's dig into this mess ADI Global Distribution has found itself in. If you were hanging onto ADIG shares, your portfolio probably took quite the hit when they revealed a nasty $659 million goodwill write-down. Imagine opening up those financials and seeing about 62% of goodwill value wiped out overnight. Suddenly, that...

Continue Reading
AppLovin Faces Serious Investor Lawsuit Deadline

Updated Category News Views 162

Investors' Trust Shaken: The AppLovin Controversy Well, what do we have here? Another day, another hefty lawsuit coming down the pike. The spotlight’s on AppLovin Corporation (NASDAQ: APP), where the Hagens Berman law sharks are sniffing blood in the water over what they claim are federal securities law violations. The core of this legal storm swirls around AppLovin's...

Continue Reading

Top 5 Most Recently Viewed Articles

Alta Equipment Group's Dividend Declaration and Company Overview

Updated Category News Views 52

Recent Dividend Announcement from Alta Equipment Group Alta Equipment Group Inc. (NYSE: ALTG), a prominent player in premium material handling and construction equipment, has recently made headlines with the announcement of its latest quarterly dividend. The Board of Directors has sanctioned a dividend amounting to $0.057 per share for its common stock, reflecting the...

Continue Reading
I Peace Unveils Innovative iPSC Lines for Better Therapy Access

Updated Category News Views 331

I Peace Introduces New iPSC Lines to Enhance Cell Therapy Leading the way in regenerative medicine, I Peace, Inc. has proudly announced the development of new induced pluripotent stem cell (iPSC) lines that aim to significantly reduce the risk of immune rejection among patients. This groundbreaking innovation is particularly relevant for the U.S. population, where over...

Continue Reading
Vendasta Welcomes New Board Members for AI Innovation

Updated Category News Views 189

Vendasta Strengthens Leadership with New Board Appointments Vendasta has made significant strides recently by welcoming two prominent figures to its Board of Directors. The company, renowned for its innovative AI solutions for small businesses, is excited to onboard Eric Johnson, formerly CEO of SurveyMonkey, and Brent Remai, the long-serving CMO of Cloudflare. Their...

Continue Reading
DICK'S Sporting Goods Expands Offer with Foot Locker Notes Exchange

Updated Category News Views 166

DICK'S Sporting Goods Moves Forward in Foot Locker Notes Exchange DICK'S Sporting Goods, Inc. (NYSE: DKS), a prominent U.S.-based retailer specializing in sporting goods, has made a key announcement regarding an exchange offer for Foot Locker, Inc.'s outstanding notes. This exchange is part of DICK'S broader strategy to enhance its financial flexibility and grow its...

Continue Reading
Northwell Health Unveils Institute of Translational Research

Updated Category News Views 195

Northwell Health Launches New Institute for Research Northwell Health, a leader in medical research, has announced the establishment of its sixth research institute, now known as the Institute of Translational Research. This new institute intends to bridge the gap between basic molecular mechanisms of chronic diseases and the development of innovative clinical therapies....

Continue Reading